Plaintiffs Robert K. and Carlesa K. have filed a lawsuit against the Monsanto Company, alleging that they suffered from the use of the herbicide Roundup product and its active ingredient glyphosate.
According to the Roundup cancer lawsuit, the Roundup and its glyphosate ingredient is “defective, dangerous to human health, unfit and unsuitable to be marketed and sold in commerce, and lacked proper warnings and directions as to the dangers associated with its use.”
The Roundup cancer lawsuit argues that plaintiff Robert K., a resident and citizen of Oklahoma, sustained personal injuries due to exposure to the product, and because of that exposure developed non-Hodgkin’s lymphoma. He was diagnosed with the condition in September 2012.
The Roundup cancer lawsuit continues to purport that due to her husband’s injuries, his wife had also suffered “loss of the comfort, enjoyment, society, and services of her spouse,” which she was entitled to and allegedly deprived of.
Roundup Cancer Lawsuit Facts
The active ingredient in Roundup weed killer has been allegedly linked to an increased risk of consumers developing non-Hodgkin’s lymphoma, among other cancers. Some of these cancers associated with the product include: Leukemia, Multiple Myeloma, B-cell Lymphoma, Skin Tumors, Bone Cancer, Pancreatic Islet Cell Tumors, and other cancers.
In a report released by the International Agency for Research on Cancer (IARC) in March 2015, researchers addressed the link between cancer and Roundup’s active ingredient, glyphosate.
Other studies were also released, including one in the U.S. and other specific international studies done in Sweden and Canada. A particular Canadian study, published by the American Association for Cancer Research, found that men who have been exposed to glyphosate were developing the non-Hodgkin’s lymphoma condition “after being exposed to the chemical for under 10 years.”
The U.S. study, published in the Occupational and Environmental Medicine Journal concluded that glyphosate was “potentially carcinogenic” and was “associated with increased NHL (non-Hodgkin’s lymphoma) incidence.”
Although the Environmental Protection Agency (EPA) began to suspect a link between glyphosate and non-Hodgkin’s lymphoma, researchers in the studies really began to consider the possible correlation between glyphosate and non-Hodgkin’s lymphoma after they started to observe the increased number of farmers being diagnosed with the condition.
The Monsanto Company has faced several lawsuits filed by consumers who have developed non-Hodgkin’s lymphoma allegedly because of using the Roundup product.
The Roundup Cancer lawsuit says to Monsanto that glyphosate, the active ingredient in Roundup, can be of no use in commercial crops.
The plaintiffs accuse Monsanto of marketing a dangerous product, and states that the “defendant did act together to design, sell, advertise, manufacture and/or distribute Roundup, with full knowledge of its dangerous and defective nature.”
Accordingly, moreover, the Roundup cancer lawsuit contends, “defendants have known of this association since the early mid-1980s and numerous human and animal studies have evidenced the carcinogenicity of glyphosate and/or Roundup.”
The Roundup Cancer Lawsuit is Case No. 4:17-cv-02171, in the U.S. District Court for the Eastern District of Missouri.
If you or a loved one developed cancer after using Roundup as a farm worker or home gardener, you may have a legal claim. Legal migrant farm workers may also seek help. Learn more by filling out the form on this page for a FREE case evaluation.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Roundup Cancer Class Action Lawsuit Investigation
For the most up-to-date information on this case, click here.
Oops! We could not locate your form.